Daily Judi: Friday, March 31, 2023
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Jill Wechsler examines the planned end on May 11, 2023, of the U.S. federal Public Health Emergency for COVID-19. (Applied Clinical Trials)
Neurologylive speaks with Melanie Quintana, PhD, on clinical trial design for ALS research, at the recent 2023 Muscular Dystrophy Association Clinical & Scientific Conference, held March 19-22, in Dallas, Texas.
Kristin Jensen reports that GSK plans to purchase rights from Scynexis for $90 million to an antifungal treatment, with potential payments in the future. The two companies intend to market a treatment for invasive candidiasis, a serious infection that can affect the heart, brain, and other parts of the body. (BioPharma Dive)
Our Culture
“My favorite thing about working for AG Mednet is its diversity; the potential to grow, and to learn.”
–Sirisha, Software Engineer
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 133,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.